Carboplatin, paclitaxel, and pembrolizumab followed by pembrolizumab maintenance for primary treatment of incompletely resected epithelial ovarian cancer

Carboplatin, paclitaxel, and pembrolizumab followed by pembrolizumab maintenance for primary treatment of incompletely resected epithelial ovarian cancer

ObjectiveIncompletely resected epithelial ovarian cancer represents a poor prognostic subset of patients. Novel treatment strategies are needed to improve outcomes for this population. We evaluated a treatment strategy combining platinum-based chemotherapy with pembrolizumab followed by pembrolizuma...

Popoln opis

Bibliografske podrobnosti
Main Authors: Denise Uyar, Chad M. Michener, Erin Bishop, Elizabeth Hopp, Pippa Simpson, Liyun Zhang, Janet S. Rader, Peter G. Rose, Haider S. Mahdi, Robert Debernardo, Qiana Christian, William Bradley
Format: Article
Jezik:English
Izdano: Frontiers Media S.A. 2024-02-01
Serija:Frontiers in Oncology
Teme:
ovarian cancer
chemotherapy
immunotherapy
incomplete resection
gynecologic oncologic surgery
Online dostop:https://www.frontiersin.org/articles/10.3389/fonc.2024.1291090/full

Internet

https://www.frontiersin.org/articles/10.3389/fonc.2024.1291090/full

Podobne knjige/članki